2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
L

2020 ASCO Update on Recurrent Ovarian Cancer: Does Maintenance PARPi Improve OS After Response to Platinum-Based Therapy?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Lainie Martin
By 2020 ASCO Virtual Direct™ Highlights FEATURING Lainie Martin
169 views
September 30, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley
GYN
10:52

2020 ASCO Update in on Recurrent Ovarian Cancer: What Is the Impact …

2020 ASCO Virtual Direct™ Highlights

L. Martin

18 views
07:24

2020 ASCO Update on Recurrent Ovarian Cancer: Does Maintenance PARPi…

2020 ASCO Virtual Direct™ Highlights

L. Martin

169 views
08:54

2020 ASCO Highlights on PARPi in Recurrent Ovarian Cancer: Can a Non…

2020 ASCO Virtual Direct™ Highlights

L. Martin

74 views
07:08

2020 ASCO Update on Cervical Cancer: Is SLN Biopsy Alone Oncological…

2020 ASCO Virtual Direct™ Highlights

L. Martin

114 views